APRE icon

Aprea Therapeutics
APRE

Overview Fund Trends Analyst Outlook Journalist POV

40 hedge funds and large institutions have $4.5M invested in Aprea Therapeutics in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

53% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 15

57% less capital invested

Capital invested by funds: $10.4M → $4.5M (-$5.86M)

Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.11M
Puts
$23K
Net Calls
Net Calls Change

Top Buyers

1
+$92K
2
+$85.1K
3
+$38K
4
CSS
Cubist Systematic Strategies
Connecticut
+$38K
5
Two Sigma Investments
Two Sigma Investments
New York
+$35K

Top Sellers

1
-$1.25M
2
-$636K
3
-$308K
4
PP
PDT Partners
New York
-$211K
5
Citadel Advisors
Citadel Advisors
Florida
-$160K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$28K
27
$26K
28
$24K
29
$22K
30
$19K
31
$10K
32
$8K
33
$7K
34
$3K
35
$3K
36
$2K
37
$1K
38
$1K
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
1
2